Chr15q25 Genetic Variant rs16969968 Alters Cell Differentiation in Respiratory Epithelia
- PMID: 34206324
- PMCID: PMC8268843
- DOI: 10.3390/ijms22136657
Chr15q25 Genetic Variant rs16969968 Alters Cell Differentiation in Respiratory Epithelia
Abstract
The gene cluster region, CHRNA3/CHRNA5/CHRNB4, encoding for nicotinic acetylcholine receptor (nAChR) subunits, contains several genetic variants linked to nicotine addiction and brain disorders. The CHRNA5 single-nucleotide polymorphism (SNP) rs16969968 is strongly associated with nicotine dependence and lung diseases. Using immunostaining studies on tissue sections and air-liquid interface airway epithelial cell cultures, in situ hybridisation, transcriptomic and cytokines detection, we analysed rs16969968 contribution to respiratory airway epithelial remodelling and modulation of inflammation. We provide cellular and molecular analyses which support the genetic association of this polymorphism with impaired ciliogenesis and the altered production of inflammatory mediators. This suggests its role in lung disease development.
Keywords: airway epithelial cells; differentiation; inflammation; remodelling; rs16969968.
Conflict of interest statement
Ruaux reports grants and personal fees from Sanofi-Aventis outside the submitted work. Deslée reports personal fees from Nuvaira, personal fees from BTG/PneumRx, personal fees from Chiesi, personal fees from Boehringer, personal fees from Astra Zeneca, outside the submitted work. Dormoy reports personal fees from Chiesi outside the submitted work. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- Lam D.C.-L., Luo S.Y., Fu K.-H., Lui M.M.-S., Chan K.-H., Wistuba I.I., Gao B., Tsao S.-W., Ip M.S.-M., Minna J.D. Nicotinic Acetylcholine Receptor Expression in Human Airway Correlates with Lung Function. Am. J. Physiol. Lung Cell. Mol. Physiol. 2016;310:L232–L239. doi: 10.1152/ajplung.00101.2015. - DOI - PMC - PubMed
-
- Cho M.H., McDonald M.-L.N., Zhou X., Mattheisen M., Castaldi P.J., Hersh C.P., DeMeo D.L., Sylvia J.S., Ziniti J., Laird N.M., et al. Risk Loci for Chronic Obstructive Pulmonary Disease: A Genome-Wide Association Study and Meta-Analysis. Lancet Respir. Med. 2014;2:214–225. doi: 10.1016/S2213-2600(14)70002-5. - DOI - PMC - PubMed
-
- SpiroMeta Consortium. International COPD Genetics Consortium. Sakornsakolpat P., Prokopenko D., Lamontagne M., Reeve N.F., Guyatt A.L., Jackson V.E., Shrine N., Qiao D., et al. Genetic Landscape of Chronic Obstructive Pulmonary Disease Identifies Heterogeneous Cell-Type and Phenotype Associations. Nat. Genet. 2019;51:494–505. doi: 10.1038/s41588-018-0342-2. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
